The FTC's New Year's Resolution to stop the deceptive practices of some of the country's biggest diet pill makers has succeeded. On Jan. 4, the FTC announced that the marketers of four products--Xenadrine EFX, CortiSlim, TrimSpa, and One-A-Day WeightSmart--have settled with the agency, surrendering cash and other assets worth at least $25 million.
"You won't find weight loss in a bottle of pills that claims it has the latest scientific breakthrough or miracle ingredient," said FTC Chairman Deborah Platt Majoras. "Paying for fad science is a good way to lose cash, not pounds."
According to the FTC's complaint, the defendants made false or unsubstantiated claims
about their weight loss products. For example, marketers for Xenadrine EFX, claimed the pill was clinically proven to cause rapid and substantial weight loss. However, studies proved this claim to be invalid. In one study, subjects taking a placebo actually lost more weight than a study group taking the diet pill.
?Other misleading advertising claims included TrimSpa, which called their pill "Your high speed dream body diet pill" and One-A-Day WeightSmart's claim to reverse the trend that "most women over 30 can gain 10 pounds a decade."
In addition to the total $25 million settlement, the companies agreed to limit their future advertising claims.